• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 19th, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
Former FTX Chief Executive Sam Bankman-Fried, who faces fraud charges over the collapse of the bankrupt cryptocurrency exchange, leaves following a hearing at Manhattan federal court in New York City, U.S. January 3, 2023. REUTERS/Andrew Kelly/File Photo
Former FTX Chief Executive Sam Bankman-Fried, who faces fraud charges over the collapse of the bankrupt cryptocurrency exchange, leaves following a hearing at Manhattan federal court in New York City, U.S. January 3, 2023. REUTERS/Andrew Kelly/File Photo
Former FTX Chief Executive Sam Bankman-Fried, who faces fraud charges over the collapse of the bankrupt cryptocurrency exchange, leaves federal court in New York City, U.S., February 9, 2023. REUTERS/Mike Segar/File Photo
Former FTX Chief Executive Sam Bankman-Fried, who faces fraud charges over the collapse of the bankrupt cryptocurrency exchange, leaves federal court in New York City, U.S., February 9, 2023. REUTERS/Mike Segar/File Photo
Home
Litigation

Sam Bankman-Fried needs more Adderall to focus at trial, lawyers say

October 16th, 2023 | 13:05 PM Litigation 2

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

Abbott settles appeal over $495 million infant formula verdict
Maine governor says NextEra-Dominion merger will limit competition, raise energy cost concerns
Indian regulator inspects Pernod plant, collects whisky samples in wider industry probe
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results
By Reuters

Sam Bankman-Fried needs a higher Adderall dose to focus at his fraud trial and decide whether to testify in his own defense, his lawyers said.

In a late Sunday letter to U.S. District Judge Lewis Kaplan, Bankman-Fried’s lawyers said the one dose of Adderall the FTX cryptocurrency exchange founder is being given at jail early each morning to treat his attention deficit hyperactivity disorder wears off by the time the trial day starts.

“As we approach the defense case and the critical decision of whether Mr. Bankman-Fried will testify, the defense has growing concern that because of Mr. Bankman-Fried’s lack of access to Adderall he has not been able to concentrate at the level he ordinarily would,” his lawyers wrote.

Since his trial on charges of stealing billions of dollars in FTX customer funds kicked off on Oct. 3 in Manhattan federal court, Bankman-Fried has been seen during testimony typing on a laptop and whispering to his lawyers.

Prosecutors accused the 31-year-old former billionaire of laughing during the testimony of star witness Caroline Ellison, the onetime chief executive officer of his Alameda Research hedge fund and former girlfriend. His lawyer, Mark Cohen, called that charge “ridiculous.”

Bankman-Fried has pleaded not guilty to two counts of fraud and five conspiracy counts tied to FTX’s November 2022 collapse, arguing that while he made mistakes running the exchange, he did not steal money.

Prosecutors have said they may rest their case as soon as Oct. 26. Defendants in U.S. criminal cases have no obligation to present evidence, and taking the stand carries the risk of being subjected to probing cross-examination by prosecutors.

But Bankman-Fried has defied the conventional playbook for white collar defendants of remaining largely silent. He published blog posts a month after his Dec. 12, 2022 arrest, and shared Ellison’s private writings with a New York Times reporter.

Kaplan said that likely amounted to witness tampering on Aug. 11 and remanded him to Brooklyn’s Metropolitan Detention Center.

In their letter, Bankman-Fried’s lawyers proposed he be given a 12-hour extended release dose of Adderall before he leaves for the courthouse each morning. They said an MDC lawyer had not responded to their emails or calls.

The Federal Bureau of Prisons, which runs MDC, did not immediately respond to a request for comment.

  • Topic
  • USA
  • BANKMANFRIED/ (PIX)
Facebook Twitter Google+ LinkedIn Pinterest
Previous article Abbott settles appeal over $495 million infant formula verdict

Related Posts

Litigation
August 19th, 2026

Abbott settles appeal over $495 million infant formula verdict

Litigation
August 19th, 2026

Maine governor says NextEra-Dominion merger will limit competition, rais...

Litigation
August 19th, 2026

Indian regulator inspects Pernod plant, collects whisky samples in wider...

Litigation
August 19th, 2026

VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts aw...

Litigation
August 19th, 2026

Greater regulatory scrutiny no bar to mining mergers, bosses say

Litigation
August 19th, 2026

Moderna shares surge as melanoma vaccine with Merck succeeds in large tr...

The Wire
Aug 19th 4 h ago
Government

DOJ argues Comey novel shows he knew ‘86 47’ post was a thr...

Aug 19th 4 h ago
Business

Fed policymakers' inflation concerns increased at July meet...

Aug 19th 4 h ago
Sports

Swiss rider Poncini dies in Manx GP qualifying

Aug 19th 5 h ago
Business

Amazon plans drone delivery expansion to about 500 US local...

Aug 19th 5 h ago
Litigation

Abbott settles appeal over $495 million infant formula verd...

TRENDING ON FINANCETIME
Aug 19th, 2026 Sports

Mets' Jorge Polanco (ankle) to have season-ending surgery

Aug 19th, 2026 Sports

Reports: Phillies sign free agent LHP Nestor Cortes

Aug 19th, 2026 Business

US CFTC seeks comment on compute derivatives as AI demand grows

Aug 19th, 2026 Technology

Payments firm Stripe to buy AI developer platform OpenRouter

Aug 19th, 2026 Government

ABC says intimidation by Trump's FCC forced programming changes

Markets-Sectors
ENERGY -0.16%
FINANCIALS -0.62%
TECHNOLOGY -1.07%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT